List of Avandamet drug patents
Avandamet is owned by Sb Pharmco.
Avandamet contains Metformin Hydrochloride; Rosiglitazone Maleate.
Avandamet has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Avandamet are:
- US8236345
Avandamet was authorised for market use on 10 October, 2002.
Avandamet is available in tablet;oral dosage forms.
The generics of Avandamet are possible to be released after 07 October, 2022.
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8236345 | SB PHARMCO | Composition and use |
Oct, 2022
(5 months ago) | |
Drugs and Companies using METFORMIN HYDROCHLORIDE; ROSIGLITAZONE MALEATE ingredient
Market Authorisation Date: 10 October, 2002
Treatment: NA
Dosage: TABLET;ORAL
AVANDAMET family patents
5
United Kingdom
3
Australia
3
China
3
European Union
2
United States
2
Argentina
2
Japan
1
Israel
1
South Africa
1
Denmark
1
OA
1
Slovakia
1
Austria
1
Mexico
1
Egypt
1
Hong Kong
1
Slovenia
1
Hungary
1
Morocco
1
Uruguay
1
Norway
1
AP
1
Germany
1
Colombia
1
Brazil
1
Croatia
1
Algeria
1
Portugal
1
Yugoslavia
1
Malaysia
1
Spain
1
Peru
1
Korea, Republic of
1
Poland
1
Czech Republic
1
Taiwan, Province of China
1
Ecuador
1
Ukraine
1
Bulgaria
1
EA
1
Canada
1
New Zealand
1
ME
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic